The year before, Nyren’s lab had also spun off a company, Pyrosequencing AB, to refine and commercialize the technology. Pyrosequencing was not the firm that would bring the technology to market, however; that distinction went to Connecticut-based 454 Life Sciences, who licensed whole-genome pyrosequencing applications in 2003. 454 made chips which enabled highly efficient, parallelized sequencing reactions and released the GS20 sequencer in 2005 for the price of $500,000. The GS20 worked by attaching each individual DNA template molecule to a bead and copying it many times using polymerase chain reaction (PCR). Each bead was then loaded into a well in a microplate, where sequencing reactions would be carried out. The light from luciferase activation could be detected through the bottom of the wells, enabling sequences to be read.
Материалы по теме:
。关于这个话题，clash下载提供了深入分析
对于被保险人违反前款规定所造成的扩大的损失，保险人不承担赔偿责任。。关于这个话题，一键获取谷歌浏览器下载提供了深入分析
10:18, 3 марта 2026Мир
ВсеПолитикаОбществоПроисшествияКонфликтыПреступность